Citius Oncology

Cranford, United States

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

$25.0M raised

May 2026

Post-IPO Debt

Medical Oncology Pharmaceutical

Top Investors

Avenue Capital Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Citius Oncology

How much funding has Citius Oncology raised?

Citius Oncology has raised $25.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in May 2026.

Who are Citius Oncology's investors?

Citius Oncology's investors include Avenue Capital Group.

Where is Citius Oncology headquartered?

Citius Oncology is headquartered in Cranford, United States.

What does Citius Oncology do?

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

What stage is Citius Oncology at?

Citius Oncology is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2026.

MLA

"Citius Oncology — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/citius-oncology. Accessed July 2, 2026.

APA

VCBacked. (2026). Citius Oncology — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/citius-oncology

Wikipedia (cite web)

{{cite web |title=Citius Oncology — Funding & Investors |url=https://www.vcbacked.co/company/citius-oncology |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2026.

Similar Companies in Medical